AG
RVMD icon

Algert Global’s Revolution Medicines RVMD Stock Holding History

Algert Global’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75,020
Closed -$7.3M – 1390
2026
Q1 		$7.3M Sell
75,020
-38,910
-34% -$3.93M 0.11% 317
2025
Q4 		$9.07M Sell
113,930
-52,385
-31% -$3.43M 0.14% 237
2025
Q3 		$7.77M Buy
166,315
+97,332
+141% +$3.81M 0.13% 264
2025
Q2 		$2.54M Buy
68,983
+22,010
+47% +$846K 0.05% 559
2025
Q1 		$1.66M Hold
46,973
– – 0.04% 654
2024
Q4 		$2.05M Buy
46,973
+6,925
+17% +$349K 0.05% 602
2024
Q3 		$1.82M Hold
40,048
– – 0.05% 586
2024
Q2 		$1.55M Buy
40,048
+33,588
+520% +$1.26M 0.05% 544
2024
Q1 		$208K Sell
6,460
-14,140
-69% -$419K 0.01% 967
2023
Q4 		$591K Buy
+20,600
New +$495K 0.02% 769
2023
Q2 		– Sell
-54,627
Closed -$1.18M – 1230
2023
Q1 		$1.18M Sell
54,627
-55,163
-50% -$1.36M 0.06% 578
2022
Q4 		$2.62M Sell
109,790
-18,320
-14% -$390K 0.14% 214
2022
Q3 		$2.53M Buy
128,110
+104,730
+448% +$2.3M 0.15% 204
2022
Q2 		$456K Buy
+23,380
New +$455K 0.03% 790
2021
Q4 		– Sell
-15,272
Closed -$420K – 1097
2021
Q3 		$420K Buy
15,272
+4,582
+43% +$133K 0.06% 611
2021
Q2 		$339K Sell
10,690
-160
-1% -$5.58K 0.11% 259
2021
Q1 		$498K Buy
10,850
+674
+7% +$30.2K 0.16% 205
2020
Q4 		$403K Buy
+10,176
New +$402K 0.11% 252

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Algert Global's RVMD Position: Q2 2026 in Review

Algert Global sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 75,020 shares — an estimated $7.3M sold.

Algert Global first reported a position in RVMD in Q4 2020 and held it in 18 quarters. The position peaked at $9.07M in Q4 2025. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Algert Global reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 75,020 Revolution Medicines shares in Q2 2026, an estimated $7.3M.
  • Algert Global first reported a position in Revolution Medicines in Q4 2020 and held it in 18 quarters.
  • Algert Global's Revolution Medicines position peaked at $9.07M in Q4 2025.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.